Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Tomoya, Funada"'
Autor:
Shunji Okada, Shintaro Yamazaki, Teruo Kaiga, Tomoya Funada, Mitsugu Kochi, Tadatoshi Takayama
Publikováno v:
World Journal of Surgical Oncology, Vol 15, Iss 1, Pp 1-7 (2017)
Abstract Background The nutritional status plays a pivotal role during anticancer therapy. This study analyzed whether nutritional status influences the outcomes in the era of FOLFOX/FIRI therapy. Methods The patients were divided into two groups acc
Externí odkaz:
https://doaj.org/article/7ba61a142ccf469d9cfd2a34c8bbf032
Autor:
Yuusuke Mitsuka, Shintaro Yamazaki, Taiki Miyakuni, Atsuko Iwama, Tomoya Funada, Yoshifumi Watanabe, Teruo Kaiga, Shunji Okada, Mitsugu Kochi, Tadatoshi Takayama
Publikováno v:
Case Reports in Gastroenterology, Vol 4, Iss 2, Pp 238-242 (2010)
The prognosis of malignant peritoneal mesothelioma is extremely poor with a mean survival time of 12 months. The initial symptoms are poor and atypical. Because of its rare entity and little knowledge of its treatments, there are few reports of long-
Externí odkaz:
https://doaj.org/article/0fc3ff1047584f8989cd851ccf241868
Publikováno v:
European Surgery. 50:183-188
Segmental non-anatomical colectomy is a current proposed minimally invasive but non-anatomical procedure. However, few studies have compared its efficacy to that of anatomical colectomy. To evaluate the prognostic impact of anatomical vs. non-anatomi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tomoya Funada, Youichi Teshima, Daijo Jinno, Masashi Fujii, Tadatoshi Takayama, Mitsugu Kochi, Noriaki Kanamori, Yoshiaki Mihara
Publikováno v:
American Journal of Clinical Oncology. 40:381-385
To assess the clinical significance of preservation of the inferior mesenteric artery (IMA) in comparison with IMA ligation in surgery for sigmoid colon or rectal (colorectal) cancer.Consecutive patients (n=862) with colorectal cancer who underwent i
Autor:
Hidenori Tamegai, Megumu Watanabe, Tomoya Funada, Yoshiaki Mihara, Yuriko Takayama, Noriaki Kanamori, Tadatoshi Takayama, Masashi Fujii, Hiroshi Suda, Mitsugu Kochi
Publikováno v:
American Journal of Clinical Oncology. 40:17-21
We conducted a phase II trial to investigate the efficacy and safety of neoadjuvant chemotherapy (NAC) comprising S-1 and cisplatin (CDDP) followed by extensive resection in the management of resectable locally advanced gastric cancer with lymph node
Autor:
Tomoya Funada, Mitugu Kochi, Yoshiaki Mihara, Chiharu Ebara, Shintaro Yamazaki, Tadatoshi Takayama
Publikováno v:
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association). 75:1346-1350
Autor:
Hidenori Tamegai, Yoshiaki Mihara, Tomoya Funada, Masashi Fujii, Teruo Kaiga, Tadatoshi Takayama, Hiroko Shimizu, Noriaki Kanamori, Mitsugu Kochi, Daijo Jinno
Publikováno v:
Cancer Chemotherapy and Pharmacology. 71:727-731
The purpose of this study was to investigate whether intravenous (i.v.) administration allowed docetaxel to penetrate ascites in gastric cancer patients with peritoneal dissemination.Twelve patients with disseminated gastric carcinoma were enrolled i
Autor:
Mitsugu Kochi, Megumu Watanabe, Tomoya Funada, Hidenori Tamegai, Yuriko Takayama, Masashi Fujii, Tadatoshi Takayama, Hiroshi Suda, Noriaki Kanamori, Yoshiaki Mihara
Publikováno v:
Journal of Cancer Therapy. :720-725
The purpose of this study was to investigate the clinicopathological features of gastric precedence (GP) and colorectal precedence (CP) metachronous double primary gastric and colorectal cancer (MDPGCC) and determine the biological significance of th
Autor:
Tomoya Funada, Teruo Kaiga, Shunji Okada, Mitsugu Kochi, Tadatoshi Takayama, Yoshifumi Watanabe, Shintaro Yamazaki, Yuusuke Mitsuka, Atsuko Iwama, Taiki Miyakuni
Publikováno v:
Case Reports in Gastroenterology
Case Reports in Gastroenterology, Vol 4, Iss 2, Pp 238-242 (2010)
Case Reports in Gastroenterology, Vol 4, Iss 2, Pp 238-242 (2010)
The prognosis of malignant peritoneal mesothelioma is extremely poor with a mean survival time of 12 months. The initial symptoms are poor and atypical. Because of its rare entity and little knowledge of its treatments, there are few reports of long-